Recent advances in sialidase inhibitors

Bibliography

• GOTTSCHALK A: Neuraminidase: the specific enzyme of influenza virus and Vibrio cholerae. Biochem. Bio-phys. Acta (1957) 23:645–646.
   PubMedGoogle Scholar
• LIU C, EICHELBERGER MC, COMPANS RW, AIR GM: Influ-enza Type A virus neuraminidase does not play a role in viral entry, replication, assembly, or budding. J. Vi-rol. (1995) 69:1099–1106.
   Google Scholar
• BAMFORD MJ: Neuraminidase inhibitors as potential anti-influenza drugs. J. Enzyme Inhibition (1995) 10:1–16.
   Google Scholar
• MEINDL P, BODO G, PALESE P, SCHULMAN J, TUPPY H: Inhibition of neuraminidase activity by derivatives of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid. Virol-ogy (1974) 58(2):457–463.
   PubMedGoogle Scholar
• PALESE P, SCHULMAN JL, BODO G, MEINDL P: Inhibition of influenza and parainfluenza virus replication in tis-sue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA). Virology (1974) 59(2)490–498.
   Google Scholar
• VON ITZSTEIN M, WU WY, KOK GB et al.: Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature (1993) 363(6428) :418–423.
   PubMed Web of Science ®Google Scholar
• ••Disclosure in the primary literature of the rational design ofzanamivir.
   Google Scholar
• SMITH PW, SOLLIS SL, HOWES PD et al.: Dihydropyran-carboxamides related to zanamivir: a new series of in-hibitors of influenza virus sialidases. 1. Discovery, synthesis, biological activity, and structure-activity re-lationships of 4-guanidino- and 4-amino-411-pyran-6-carboxamides. J. Med. Chem. (1998) 41(6):787–797.
   Google Scholar
• TAYLOR NR, CLEASBY A, SINGH O et al.: Dihydropyran-carboxamides related to zanamivir: a new series of in-hibitors of influenza virus sialidases. 2. Crystallographic and molecular modeling study of complexes of 4-amino-411-pyran-6-carboxamides and sialidase from influenza virus types A and B. J. Med. Chem. (1998) 41(6):798–807.
   Google Scholar
• VARGHESE JN, EPA VC, COLMAN PM: Three-dimensional structure of the complex of 4-guanidino-Neu5Ac2en and influenza virus neuraminidase. Protein Sci. (1995) 4:1081–1087.
   PubMed Web of Science ®Google Scholar
• KIM CU, LEW W, WILLIAMS MA et al.: Influenza neu-raminidase inhibitors possessing a novel hydropho-bic interaction in the enzyme active site: design, synthesis and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity. J. Amer. Chem. Soc. (1997) 119:681–690.
   PubMed Web of Science ®Google Scholar
• WALLIMAN K, VASELLA A: Phosphonic-acid analogues of the N-acetyl-2-deoxyneuraminic acids: synthesis and inhibition of Vibrio cholerae sialidase. Hely. Chim. Acta (1990) 73:1359–1372.
   Google Scholar
• SINGH S, JEDRZEJAS MJ, AIR GM, LUO M, LAVER WG, BROUILLETTE WJ: Structure-based inhibitors of influ-enza virus sialidase. A benzoic acid lead with novel in-teraction. J. Med. Chem. (1995) 38:3217–3225.
   Google Scholar
• •Describes the alternative binding mode of aromatic gua-nidino benzoic acids.
   Google Scholar
• LUO M, AIR GM, BROUILLETTE WJ: Design of aromatic inhibitors of influenza virus neuraminidase. Int. Congr. Ser. (1996) 1123:702–712.
   Google Scholar
• WADE RC, CLARK KJ, GOODFORD PJ: Further develop-ment of hydrogen bond functions for use in determin-ing energetically favorable binding sites on molecules of known structure. 1. Ligand probe groups with the ability to form two hydrogen bonds. J. Med. Chem. (1993) 36(0:140–147.
   Google Scholar
• WADE RC, CLARK KJ, GOODFORD PJ: Further develop-ment of hydrogen bond functions for use in determin-ing energetically favorable binding sites on molecules of known structure. 2. Ligand probe groups with the ability to form more than two hydrogen bonds. J. Med. Chem. (1993) 36(1):148–156.
   Google Scholar
• BASHFORD D, KARPLUS M: pKa's of ionizable groups in proteins: atomic detail from a continuum electrostatic model. Biochemistry (1990) 29(44):10219–10225.
   PubMedGoogle Scholar
• DAVIS ME, MADURA JD, LUTY BA, MCCAMMON JA: Elec-trostatics and diffusion of molecules in solution: simu-lations with the University of Houston Brownian dynamics program. Comput. Phys. Commun. (1991) 62(2-3):187–197.
   Web of Science ®Google Scholar
• GILSON MK, SHARP KA, HONIG BH: Calculating the elec-trostatic potential of molecules in solution: method and error assessment. J. Comput. Chem. (1988) 9(4)327–335.
   Google Scholar
• JUFFER AH, BOTTA EFF, VAN KEULEN BAM, VAN DER PLOEG A, BERENDSEN HJC: The electric potential of a macromolecule in a solvent: a fundamental approach. Comput. Phys. (1991) 97(0:144–171.
   Google Scholar
• DUARTE FJ, BABU YS, BANTIA S et al.: Substituted ben-zoic acids as inhibitors of influenza neuraminidase. 2 13th ACS National Meeting. San Francisco, USA (April 3–17, 1997). MEDI–276.
   Google Scholar
• •Gives the first indication that compounds based upon a ben-zene template may give rise to potent inhibitors of influenza virus sialidases.
   Google Scholar
• ATIGADDA V, BABU YS, BANTIA S et al. New aromatic inhibitors of influenza neuraminidase. 213th ACS National Meeting. San Francisco, USA (April 3–17, 1997). MEDI–275.
   Google Scholar
• WILLIAMS M, BISCHOFBERGER N, SWAMINATHAN S, KIM CU: Synthesis and influenza neuraminidase inhibitory activity of aromatic analogs of sialic acid. Bioorg. Med. Chem. Lett. (1995) 5:2251–2254.
   Google Scholar
• WILLIAMS MA, LEW W, MENDEL DB, TAI CY, ESCARPE PA, LAVER WG, STEVENS RC, KIM CU: Structure-activity rela-tionships of carbocyclic influenza neuraminidase in-hibitors. Bioorg. Med. Chem. Lett. (1997) 7 (14) :1837–1842.
   Google Scholar
• ••Paper describing important SAR around GS4071, togetherwith a rationale for the observed potency.
   Google Scholar
• LEW W, WILLIAMS MA, MENDEL DB, ESCARPE PA, KIM CU: C3-Thia and C3-carba isosteres of a carbocyclic in-fluenza neuraminidase inhibitor, (3R,4R,5R)-4-acetamido-5-amino-3-propoxy-1-cyclohexene-1-car boxylic acid. Bioorg. Med. Chem. Lett. (1997) 7 (14):1843–1846.
   Google Scholar
• ••Paper describing important SAR around G54071, togetherwith a rationale for the observed potency.
   Google Scholar
• ZHANG L, WILLIAMS MA, MENDEL DB, ESCARPE PA, KIM CU: Synthesis and activity of C2-substituted analogs of influenza neuraminidase inhibitor GS 4071. Bioorg. Med. Chem. Lett. (1997) 7 (1 4):1847–1850.
   Google Scholar
• ••Paper describing important SAR around G54071, togetherwith a rationale for the observed potency.
   Google Scholar
• SIDWELL RW, HUFFMAN JH, BARNARD DL et al.: Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase in-hibitor. Antiviral Res. (1998) 37 (2) :107–120.
   PubMed Web of Science ®Google Scholar
• •Comparison of zanamivir, G54071 and GS4104 in the treat-ment of influenza.
   Google Scholar
• ROHLOFF JC, KENT KM, POSTICH MJ et al: Practical total synthesis of the anti-influenza drug GS4104. J. Org. Chem. (1998) 63(13):4545–4550.
   Web of Science ®Google Scholar
• SABESAN S, BOCK K, PAULSON JC: Conformational analysis of sialyloligosaccharides. Carbohydr. Res. (1991) 218:27–54.
   PubMed Web of Science ®Google Scholar
• CHAND P, BABU YS, BANTIA S et al. Design and synthesis of benzoic acid derivatives as influenza neuramini-dase inhibitors using structure-based drug design. J. Med. Chem (1997) 40(25)4030–4052.
   Google Scholar
• HAYDEN FG, OSTERHAUS ADME, TREANOR JJ et al.: Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza virus infec-tion. New Engl. J. Med. (1997) 337:874–880.
   PubMedGoogle Scholar
• •Reports the effectiveness of zanamivir when used to treat clinical influenza infections.
   Google Scholar
• CHAN T-H, XIN Y-C, VON ITZSTEIN M: Synthesis of phosphonic acid analogues of sialic acids as potential sialidase inhibitors. J. Org. Chem. (1997) 62:3500–3504.
   Google Scholar